Variable
|
Open (N = 29)
|
Laparoscopy (N = 88)
|
p value
|
---|
Age (years)
|
62.2 ± 12.0
|
65.1 ± 12.8
|
0.287a
|
Gender
|
Male
|
14 (48.3)
|
46 (52.3)
|
0.709c
|
Female
|
15 (51.7)
|
42 (47.7)
|
BMI (kg/m2)
|
22.3 ± 3.2
|
23.9 ± 3.2
|
0.026a
|
ASA score
|
1, 2
|
28 (96.6)
|
87 (98.9)
|
0.436d
|
3, 4
|
1 (3.5)
|
1 (1.1)
|
Preoperative CEA (ng/ml)
|
2.4 (0.6–54.9)
|
3.3 (0.4–138)
|
0.270b
|
Location
|
Right
|
12 (41.4)
|
40 (45.5)
|
0.702c
|
Left
|
17 (58.6)
|
48 (54.6)
|
Operative time (min)
|
75 (45–505)
|
148 (85–460)
|
< .001b
|
Blood loss (ml)
|
50 (0–1000)
|
50 (0–530)
|
0.003b
|
Transfusion
|
No
|
27 (93.1)
|
88 (100)
|
0.060d
|
Yes
|
2 (6.9)
|
0 (0)
|
Hospital stay (days)
|
8 (5–36)
|
8 (4–31)
|
0.942b
|
Postoperative morbidity
|
No
|
23 (79.3)
|
70 (79.6)
|
0.978c
|
Yes
|
6 (20.7)
|
18 (20.5)
|
Postoperative morbidity type
|
Ileus
|
1 (16.7)
|
6 (33.3)
| |
Urinary retention
|
0 (0)
|
2 (11.1)
| |
Anastomotic leakage
|
0 (0)
|
1 (5.6)
| |
Surgical site infection
|
3 (50)
|
4 (22.2)
| |
Sepsis
|
0 (0)
|
1 (5.6)
| |
Others
|
2 (33.3)
|
4 (22.2)
| |
Clavien–Dindo classification
|
1, 2
|
6 (100)
|
14 (77.8)
|
0.539d
|
3
|
0 (0)
|
4 (22.2)
|
Adjuvant chemotherapy
|
No
|
1 (20.0)
|
18 (22.9)
|
1.000c
|
(N = 77)
|
Yes
|
4 (80.0)
|
54 (77.1)
|
- aTwo-sample t test
- bWilcoxon rank sum test
- cChi-square test
- dFisher’s exact test
- Data are expressed as mean ± standard deviation or median (range) for continuous variables and as number (percentage) for categorical variables
- ASA American Society of Anesthesiologists, BMI body mass index, CEA carcinoembryonic antigen